Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine from a three-year trial in Tanzania were announced by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine.
Post Tagged with: "tubercolosis"
Upcoming Events
- Research in Progress Seminars: Ao Liu & Muhammad Haseeb January 28, 2021
- Medicine Grand Rounds "Evidence-Based Causation and RTW Guidelines for the Non-Occupational Physician", Raymond H. Hicks, MD, MSc, MPH January 29, 2021
- Scopus Workshop January 29, 2021
- Dr. Anthony Faber February 1, 2021
- bioMT Seminar: Tak Shun Fung (Higgs Lab) February 2, 2021
- Systematic Review Series 4: Developing a Comprehensive Search (Part 2) February 2, 2021
- Vaccines in 2021 COVID-19 Virtual Series: COVID-19 Vaccine Communication, Misinformation, and Fear February 3, 2021
- Pediatric Grand Rounds February 3, 2021
- DartCF Seminar: Zhongyou Li (Stanton Lab) February 3, 2021
- Free Citation Managers: Zotero and Mendeley February 4, 2021
Dartmouth Medicine Magazine
